JPRN-UMIN000024686
Completed
Phase 2
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by chemoradiotherapy concurrent with fractionated administration of high-dose cisplatin for patients with locally advanced squamous cell carcinoma of the head and neck - TPF study for Japanese
ational Cancer Center Hospital East0 sites48 target enrollmentNovember 2, 2016
Conditionsocally advanced head and neck cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- ocally advanced head and neck cancer
- Sponsor
- ational Cancer Center Hospital East
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Active bacterial or fungus infection Active Malignant disease, other than that being treated in this study Pregnant or lactating women Clinically significant and/or uncontrolled heart disease History of cerebrovascular disease Uncontrolled diabetes or hypertension Severe complications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomised phase II trial - SatellitPatient with locally advanced stage III non-small cell lung cancer.EUCTR2005-003867-21-SESahlgrenska University Hospital75
Active, not recruiting
Phase 2
Induction chemotherapy for HPV positive oropharyngeal cancers (HIPPOCRATES)Human papillomavirus-associated oropharyngeal cancersHuman papillomavirus, oropharyngeal cancersJPRN-jRCT1041220029Yokota Tomoya30
Unknown
Phase 1
Combination chemotherapy with docetaxel, cisplatine, and 5-fluorouracil for patients with advanced head and neck cancer: a phase I/II trialSquamous cell carcinoma of the head and neckJPRN-UMIN000000744Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Yamanashi53
Unknown
Phase 3
Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT02786641Sun Yat-sen University235
Completed
Phase 1
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or HypopharynxHead and Neck CancerNCT00498953European Organisation for Research and Treatment of Cancer - EORTC7